Skip to content

A randomized controlled study of the effects of enhanced blood pressure management with different standards on stroke recurrence in middle-aged and elderly patients

The effects of enhanced blood pressure management with different standards on stroke recurrence in middle-aged and elderly patients : a randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037028
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral stroke

Interventions

experimental group 1:Enhanced blood pressure control 1+basic treatment
experimental group 2:Enhanced blood pressure control 2+basic treatment

Sponsors

Xi'an Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age at least 45 and under 80, regardless of ethnicity or gender; 2. Cerebral infarction (over 2 weeks); 3. Prior or current diagnosis of essential hypertension; 4. Patients participate voluntarily, have the ability to give informed consent and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Suspected hypohemodynamic cerebral infarction; 2. Bilateral carotid stenosis is 70 percent or greater; 3. Patients with cardiogenic stroke; 4. Have congestive heart failure and present unstable cardiac function; 5. Acute coronary syndrome and severe arrhythmia; 6. Severe hepatic and renal dysfunction (serum ALANINE aminotransferase 5 times higher than normal or creatinine >= 3 mg/dL); 7. Pregnant women breastfeeding women and patients who may become pregnant in the next six months; 8. Mental illness alcohol or drug dependence; 9. People with malignant tumors or other diseases who are likely to live for less than 3 years.

Design outcomes

Primary

MeasureTime frame
Blood pressure;

Secondary

MeasureTime frame
Electrocardiogram;TCD;echocardiographic;Cervical vascular ultrasound;scale;

Countries

China

Contacts

Public ContactZhengli Di

Xi'an Central Hospital

zhenglidi@126.com+86 13991161359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026